Pr Jeremy Bellien is Coordinator on an ANR international collaborative project entitled PHASM : «L'activité phosphatase de l'époxyde hydrolase soluble comme nouvelle cible dans les maladies cardiométaboliques» selected in the ANR PRCI 2022 axis «Collaboration bilatérale ANR/ DFG»
This project is developed together with Pr Ewgeinj Proschak (Heisenberg-Professor for Drug Design at the Institut für Pharmazeutische Chemie, Goethe-Universität Frankfurt am Main, Germany).
Pr Paul Mulder is Partner on an ANR collaborative project entitled POPHeart : «Impact of pollutants and AHR signaling on cardiac function in predisposed models of cardiomyopathy» proposed for the ANR PRC 2021 axis « Contaminants, écosystèmes et santé »
This project is coordinated by Dr Marianne Gervaise-Taurel (Inserm IMRB U955, Faculté de Médecine - UPEC) together with Dr Mathias Mericskay (Inserm U1180, Faculté de Pharmacie, Université Paris-Saclay).
In this project, our unit will participate with evaluations of the cardiovascular impact of dioxine in animal models of metabolic syndrome. A new PhD student, Eva Correira, will carry out this project together with ohter laboratory members under the guidance of Pr Paul Mulder.
Dioxines et leurs effets sur la santé (who.int)